-
Developing a remedy against MRSA
Methicillin Resistant Staphylococcus aureus (MRSA, see picture) is a bacterium that is resistant to most common antibiotics. Moreover, it can ‘easily change coat’ thereby developing immunity to new antibiotics as well. The bacterium is therefore difficult to treat and developing a remedy is a big challenge. In our project researchers are developing a medicine that attacks MRSA on several fronts. Read more >>
-
Development of a malaria vaccine
Current malaria medicine is expensive and insufficient to cater for all infected people. Finding an adequate vaccine for malaria is thus a pressing matter. In our project three research groups, each with their own specialties, are brought together to work on developing a new vaccine. The first step in the project is isolating a sufficient amount of the malaria-causing parasite. Read more »
-
Developing medicines for Parkinson's and Alzheimer's disease
Parkinson and Alzheimer are neurodegenerative diseases with a considerable socio-economic burden. The symptoms of both diseases are well known although they may differ between individuals. As to the cause however, researchers so far have not been able to find a conclusive answer. Our project aims to identify the genes and proteins that are involved in the development of the diseases. Read more >>
-
euSEND fights neglected tropical diseases
Neglected diseases, such as malaria, represent a major health, societal and economic burden on developing counrties. Within its project portfolio, TI Pharma is seeking to develop solutions to these diseases, mobilizing public and private partners in multilateral consortia – bringing together a wide range of competences and resources. Read more >>
Top Institute Pharma
A public-private partnership in which scientific and business worlds work together aimed at improving the development of socially valuable medicines. Our institute acts as an essential link in combining the knowledge present in science and industry.
Read more >>
Highlights
|
Spring Meeting 2012: focus on public-private partnerships |
| Selina Khan chose to work in the industry |
|
Recent news
 |
Life Sciences & Health top sector: towards innovation contracts
The Life Sciences & Health sector is recognized by the government as one of the nine top... 26 January 2012 |
 |
Huub Schellekens FD article
Huub Schellekens, doctor and professor pharmaceutical biotechnology, criticizes Dutch government in... 24 January 2012 |